Inhibition of indoleamine 2,3-dioxygenase promotes vascular inflammation and increases atherosclerosis in Apoe-/- mice

Cardiovascular Research
K A PolyzosDaniel F J Ketelhuth

Abstract

Atherosclerosis is a chronic inflammatory disease that is initiated by the retention and accumulation of low-density lipoprotein in the artery, leading to maladaptive response of cells from the immune system and vessel wall. Strong evidence implicates indoleamine 2,3-dioxygenase (IDO), the first and rate-limiting enzyme of the kynurenine pathway of tryptophan (Trp) degradation, with immune regulation and anti-inflammatory mechanisms in different diseases. However, the role of IDO and the endogenous degradation of Trp have never been directly examined in atherosclerosis development. We used the IDO inhibitor 1-methyl-Trp (1-MT) to determine the role of IDO-mediated Trp metabolism in vascular inflammation and atherosclerosis. Apoe(-/-) mice were treated with 1-MT in drinking water for 8 weeks. Systemic IDO inhibition led to a significant increase in atherosclerotic lesions that were ∼58 and 54% larger in the aortic arch and root, respectively. 1-MT treatment enhanced vascular inflammation, up-regulated VCAM-1 and CCL2, and increased CD68 macrophage accumulation into the plaque. Notably, the rise in VCAM-1 expression was not limited to the plaque but also found in smooth muscle cells (SMCs) of the tunica media. Furthermore, we fou...Continue Reading

References

Feb 13, 2001·The Journal of Clinical Investigation·A J Dal CantoH W Virgin
Aug 6, 2002·Journal of Neuroimmunology·Kenichi SakuraiGene M Shearer
Jun 10, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Andrew L Mellor, David H Munn
Jul 1, 1953·The Journal of Pathology and Bacteriology·T CRAWFORD, C I LEVENE
Jan 16, 2004·Gastroenterology·Gregory J GurtnerWilliam F Stenson
Jun 7, 2006·The Journal of Biological Chemistry·Jinghong WangLei Ling
Jun 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Maria L BelladonnaPaolo Puccetti
Oct 4, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Madison C CuffyGeorge Tellides
Jan 9, 2008·The Journal of Allergy and Clinical Immunology·Yousef A TaherAntoon J M van Oosterhout
May 5, 2010·The Journal of Experimental Medicine·Andreas HermanssonGöran K Hansson
Feb 23, 2012·Proceedings of the National Academy of Sciences of the United States of America·Buvana RavishankarTracy L McGaha
Oct 30, 2012·Trends in Immunology·David H Munn, Andrew L Mellor
Aug 21, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Manabu TakamatsuAkira Hara

❮ Previous
Next ❯

Citations

Oct 7, 2015·Proceedings of the National Academy of Sciences of the United States of America·Jennifer E ColeClaudia Monaco
May 28, 2016·Medicine and Science in Sports and Exercise·Clévia Santos PassosMirian Aparecida Boim
Sep 12, 2017·Antioxidants & Redox Signaling·Tomasz J Guzik, Francesco Cosentino
Dec 3, 2015·World Journal of Biological Chemistry·Elitsa Ananieva
Jun 23, 2018·Arteriosclerosis, Thrombosis, and Vascular Biology·Ellen Rouwet, Esther Lutgens
Feb 20, 2016·Circulation Research·Daniel F J Ketelhuth, Göran K Hansson
Jun 13, 2019·Scientific Reports·Mengyu LiCatherine Mary Schooling
Aug 15, 2020·Journal of Internal Medicine·R BaumgartnerD F J Ketelhuth
Jul 18, 2015·Clinical Science·Amanda W S YeungShane R Thomas
Mar 21, 2017·Cellular and Molecular Life Sciences : CMLS·Ping SongMing-Hui Zou
Mar 21, 2020·Frontiers in Immunology·Yi-Shu HuangTrevor W Stone
Apr 21, 2020·Frontiers in Pharmacology·Remy VillettePhilippe Lesnik
Oct 24, 2018·Research and Practice in Thrombosis and Haemostasis·Yuki WatanabeYujiro Asada
Oct 23, 2019·Signal Transduction and Targeted Therapy·Heng LiangQing Yang
Dec 6, 2019·Stem Cell Research & Therapy·Karl-Henrik GrinnemoCecilia Österholm
Sep 26, 2019·Frontiers in Immunology·Soraya Taleb
Dec 11, 2020·Journal of Atherosclerosis and Thrombosis·Masanori NishimuraYujiro Asada
Jul 19, 2020·Signal Transduction and Targeted Therapy·Heng LiangQing Yang
Apr 12, 2020·Clinical Kidney Journal·Vetalise C KonjeUNKNOWN Michigan Kidney Translational Core CPROBE Investigator Group
Jul 28, 2021·BMC Cardiovascular Disorders·Nattawut WongpraparutKittipong Maneechotesuwan
Aug 15, 2021·Nature Reviews. Immunology·Payel RoyKlaus Ley

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Cell Adhesion Molecules in AS

Cell adhesion molecules expressed on the vascular endothelium and circulating leukocytes in response to inflammatory stimuli are implicated in atherosclerosis. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.